Your browser doesn't support javascript.
loading
[Epidemiological characteristics of human respiratory syncytial virus (HRSV) among acute respiratory infection (ARI) cases in 16 provinces of China from 2009 to 2023].
Cui, A L; Xia, B C; Zhu, Z; Xie, Z B; Sun, L W; Xu, J; Xu, J; Li, Z; Zhao, L Q; Long, X R; Yu, D S; Zhu, B; Zhang, F; Mu, M; Xie, H; Cai, L; Zhu, Y; Tian, X L; Wang, B; Gao, Z G; Liu, X Q; Ren, B Z; Han, G Y; Hu, K X; Zhang, Y.
Afiliación
  • Cui AL; National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases(NITFID)/NHC Key Laboratory of Medical Virology and Viral Diseases/National Institute for Viral Disease Control and Prevention,Chinese Center for Disease Control and Prevention, Beijing 102206, China.
  • Xia BC; National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases(NITFID)/NHC Key Laboratory of Medical Virology and Viral Diseases/National Institute for Viral Disease Control and Prevention,Chinese Center for Disease Control and Prevention, Beijing 102206, China.
  • Zhu Z; National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases(NITFID)/NHC Key Laboratory of Medical Virology and Viral Diseases/National Institute for Viral Disease Control and Prevention,Chinese Center for Disease Control and Prevention, Beijing 102206, China.
  • Xie ZB; National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases(NITFID)/NHC Key Laboratory of Medical Virology and Viral Diseases/National Institute for Viral Disease Control and Prevention,Chinese Center for Disease Control and Prevention, Beijing 102206, China.
  • Sun LW; Precision Medicine Research Center, Children's Hospital of Changchun, Changchun 130061, China.
  • Xu J; Institute of Expanded Immunization Program, Henan Provincial Center for Disease Control and Prevention, Zhengzhou 450016, China.
  • Xu J; National institute for viral disease control and prevention, Shaanxi provincial center for disease control and prevention, Xi'an 710054, China.
  • Li Z; Institute for Communicable Disease Control and Prevention, Shandong Center for Disease Control and Prevention, Jinan 250014, China.
  • Zhao LQ; Laboratory of Virology, Beijing Key Laboratory of Etiology of Viral Diseases in Children, Capital Institute of Pediatrics, Beijing 100020, China.
  • Long XR; Department of Infectious Diseases, Children's Hospital Affiliated to Chongqing Medical University, Chongqing 400014, China.
  • Yu DS; Institute of Pathogen testing, Gansu Provincial Center for Disease Control and Prevention, Lanzhou 730000, China.
  • Zhu B; Virus Laboratory, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou 510120, China.
  • Zhang F; aboratory of Viral diseases, Qingdao Municipal Centre for Disease Control and Prevention, Qingdao Institute of Prevention Medicine, Qingdao 266000, China.
  • Mu M; School of Public Health, Anhui University of Science and Technology, Huainan 232001, China.
  • Xie H; Institute for Immunization and Prevention, Beijing Center for Disease Prevention and Control, Beijing Academy for Preventive Medicine, Beijing Institute of Tuberculosis Control Research and Prevention, Beijing 100013, China.
  • Cai L; Hunan Provincial Center for Disease Control and Prevention, Changsha 410005, China.
  • Zhu Y; Laboratory of Infection and Virology, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing 100045, China.
  • Tian XL; Department of Immunization Program, Neimeng Provincial Center for Disease Control and Prevention, Huhehaote 010000, China.
  • Wang B; Department of Infectious Diseases, Shenyang Prefecture Center for Disease Control and Prevention, Shenyang 110000, China.
  • Gao ZG; Institute for infectious disease prevention and treatment, Xinjiang Center for Disease Control and Prevention, Wulumuqi 830002, China.
  • Liu XQ; Laboratory of Viral Infectious Disease, Key Laboratory of Important and Emerging Viral Infectious Diseases of Jiangxi Health Commission, Jiangxi Provincial Center for Disease Control and Prevention, Nanchang 330029, China.
  • Ren BZ; Division of Diseases Detection, Shanxi Provincial Center for Disease Control and Prevention, Taiyuan 030012, China.
  • Han GY; Institute for Viral Disease Control and Prevention, Hebei Provincial Center for Disease Control and Prevention, Shijiazhuang 050021, China.
  • Hu KX; Institute of Health Inspection and Quarantine, Chinese Academy of Inspection and Quarantine, Beijing 100123, China.
  • Zhang Y; National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases(NITFID)/NHC Key Laboratory of Medical Virology and Viral Diseases/National Institute for Viral Disease Control and Prevention,Chinese Center for Disease Control and Prevention, Beijing 102206, China.
Zhonghua Yu Fang Yi Xue Za Zhi ; 58: 1-7, 2024 Feb 23.
Article en Zh | MEDLINE | ID: mdl-38403282
ABSTRACT

Objective:

To understand the epidemiological characteristics of human respiratory syncytial virus (HRSV) among acute respiratory infection (ARI) cases in 16 provinces of China from 2009 to 2023.

Methods:

The data of this study were collected from the ARI surveillance data from 16 provinces in China from 2009 to 2023, with a total of 28 278 ARI cases included in the study. The clinical specimens from ARI cases were screened for HRSV nucleic acid from 2009 to 2023, and differences in virus detection rates among cases of different age groups, regions, and months were analyzed.

Results:

A total of 28 278 ARI cases were enrolled from January 2009 to September 2023. The age of the cases ranged from<1 month to 112 years, and the age M (Q1, Q3) was 3 years (1 year, 9 years). Among them, 3 062 cases were positive for HRSV nucleic acid, with a total detection rate of 10.83%. From 2009 to 2019, the detection rate of HRSV was 9.33%, and the virus was mainly prevalent in winter and spring. During the Corona Virus Disease 2019 (COVID-19) pandemic, the detection rate of HRSV fluctuated between 6.32% and 18.67%. There was no traditional winter epidemic peak of HRSV from the end of 2022 to the beginning of 2023, and an anti-seasonal epidemic of HRSV occurred from April to May 2023. About 87.95% (2 693/3 062) of positive cases were children under 5 years old, and the difference in the detection rate of HRSV among different age groups was statistically significant (P<0.001), showing a decreasing trend of HRSV detection rate with the increase of age (P<0.001). Among them, the HRSV detection rate (25.69%) was highest in children under 6 months. Compared with 2009-2019, the ranking of HRSV detection rates in different age groups changed from high to low between 2020 and 2023, with the age M (Q1, Q3) of HRSV positive cases increasing from 1 year (6 months, 3 years) to 2 years (11 months, 3 years).

Conclusion:

Through 15 years of continuous HRSV surveillance analysis, children under 5 years old, especially infants under 6 months old, are the main high-risk population for HRSV infection. During the COVID-19 pandemic, the prevalence and patterns of HRSV in China have changed.

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: Zh Revista: Zhonghua Yu Fang Yi Xue Za Zhi Año: 2024 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: Zh Revista: Zhonghua Yu Fang Yi Xue Za Zhi Año: 2024 Tipo del documento: Article País de afiliación: China